大腸内視鏡検査用腸管前処置薬の世界市場：薬剤の種類別、流通チャネル別、地域別 - 市場規模・シェア・見通し・機会分析（2022年～2028年）

大腸がんの増加により、予測期間中、大腸内視鏡検査用腸管前処置薬に対する世界的な需要が促進されると予想されます。

当レポートでは、世界の大腸内視鏡検査用腸管前処置薬市場について調査分析し、市場力学、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、最新の情報を提供しています。

目次

第1章 調査目的と前提条件

第2章 市場範囲

第3章 市場力学・規制・動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• 市場動向
• 規制シナリオ
• 償還シナリオ
• 疫学
• PEST分析
• 最近の製品発売
• M&Aシナリオ

第4章 世界の大腸内視鏡検査用腸管前処置薬市場：薬剤の種類別（2017年～2028年）

• イントロダクション
• 等浸透圧剤
• 低浸透圧剤
• 高浸透圧剤
• 併用薬剤

第5章 世界の大腸内視鏡検査用腸管前処置薬市場：流通チャネル別（2017年～2028年）

• イントロダクション
• 病院薬局
• 小売薬局
• その他

第6章 世界の大腸内視鏡検査用腸管前処置薬市場：地域別（2017年～2028年）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋地域
• 中東
• アフリカ

第7章 競合情勢

• ヒートマップ分析
• 市場シェア分析
  • Ferring BV
  • Bayer AG
  • Braintree
  • Bausch Health Companies Inc.
  • Norgine BV
• アナリストの見解

第8章 セクション

Colonoscopy bowel preparation drugs are used in cleansing the colon for screening and detection of colorectal cancer. The drugs to be used for cleansing colon is classified as isosmotic agents, hyperosmotic agents, hyposmotic agents, and combination agents. The hyposmotic agents include a low-volume PEG preparation called PEG-3350 (PEG-SD) that requires an additional electrolyte solution (sports drink) and often combined with bisacodyl.

Market Dynamics

The increasing prevalence of colon cancer is expected to propel global demand for colonoscopy bowel preparation drugs over the forecast period. For instance, according to the Global Cancer (GLOBOCAN) statistics published in January 2020, in the U.S., annually, around 147,950 new cases of large bowel cancer are diagnosed, of which around 104,610 cases are of colon cancer and the remaining are rectal cancer.

The increasing adoption of strategies such as collaborations and acquisitions by the market players is expected to drive the market growth over the forecast period. For instance, in May 2021, Sebela Pharmaceuticals, a specialty pharmaceutical company, acquired Braintree Laboratories Inc., a prescription pharmaceuticals manufacturing company, for expanding its gastroenterology product portfolio. For instance, in January 2020, Norgine B.V. entered into an exclusive license and distribution agreement with Aspen Pharmacare, a South African pharmaceutical holding company, for distribution and commercialization of PLENVU in the Republic of Southern Africa, Lesotho, Eswatini, Botswana, and Namibia.

Moreover, rising product launches by the market players is expected to propel the market growth over the forecast period. For instance, in February 2021, Ferring Pharmaceuticals launched Clenpiq, the first ready-to-drink colonoscopy preparation. Clenpiq contains stimulant laxative sodium picosulfate, and magnesium oxide and anhydrous citric acid, which forms the osmotic laxative magnesium citrate.

Key features of the study:

This report provides in-depth analysis of the colonoscopy bowel preparation drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global colonoscopy bowel preparation drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as part of this study include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.

Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics

The global colonoscopy bowel preparation drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the colonoscopy bowel preparation drugs market

Detailed Segmentation:

Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations

Sulfate-free PEG-ELS

Low-volume PEG Preparations

Hyposmotic Agents

Hyperosmotic Agents

Oral sodium Sulfate

Magnesium Citrate

Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate

Sodium Sulfate and SF-PEG-ELS

Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel:

Hospitals Pharmacies

Retail Pharmacies

Others

Global Colonoscopy Bowel Preparation Drugs Market, By Region:

North America

By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations

Sulfate-free PEG-ELS

Low-volume PEG Preparations

Hyposmotic Agents

Hyperosmotic Agents

Oral sodium Sulfate

Magnesium Citrate

Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate

Sodium Sulfate and SF-PEG-ELS

By Distribution Channel:

Hospitals Pharmacies

Retail Pharmacies

Others

By Country:

U.S.

Canada

Latin America

By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations

Sulfate-free PEG-ELS

Low-volume PEG Preparations

Hyposmotic Agents

Hyperosmotic Agents

Oral sodium Sulfate

Magnesium Citrate

Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate

Sodium Sulfate and SF-PEG-ELS

By Distribution Channel:

Hospitals Pharmacies

Retail Pharmacies

Others

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations

Sulfate-free PEG-ELS

Low-volume PEG Preparations

Hyposmotic Agents

Hyperosmotic Agents

Oral sodium Sulfate

Magnesium Citrate

Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate

Sodium Sulfate and SF-PEG-ELS

By Distribution Channel:

Hospitals Pharmacies

Retail Pharmacies

Others

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations

Sulfate-free PEG-ELS

Low-volume PEG Preparations

Hyposmotic Agents

Hyperosmotic Agents

Oral sodium Sulfate

Magnesium Citrate

Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate

Sodium Sulfate and SF-PEG-ELS

By Distribution Channel:

Hospitals Pharmacies

Retail Pharmacies

Others

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations

Sulfate-free PEG-ELS

Low-volume PEG Preparations

Hyposmotic Agents

Hyperosmotic Agents

Oral sodium Sulfate

Magnesium Citrate

Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate

Sodium Sulfate and SF-PEG-ELS

By Distribution Channel:

Hospitals Pharmacies

Retail Pharmacies

Others

By Country:

GCC

Israel

Rest of Middle East

Africa

By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations

Sulfate-free PEG-ELS

Low-volume PEG Preparations

Hyposmotic Agents

Hyperosmotic Agents

Oral sodium Sulfate

Magnesium Citrate

Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate

Sodium Sulfate and SF-PEG-ELS

By Distribution Channel:

Hospitals Pharmacies

Retail Pharmacies

Others

By Country/Region:

South Africa

Central Africa

North Africa

Company Profiles

Ferring B.V*

Company Overview

Product Portfolio

Financial Performance

Key Highlights

Market Strategies

Bayer AG

Braintree

Bausch Health Companies Inc.

Norgine B.V.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Regulatory Scenario
• Reimbursement Scenario
• Epidemiology
• PEST Analysis
• Recent Product Launch
• Merger and Acquisition Scenario

4. Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Isosmotic Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
• Hyposmotic Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Hyperosmotic Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
• Combination Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS

5. Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Colonoscopy Bowel Preparation Drugs Market, By Region, 2017 - 2028, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
• North America
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
• Latin America
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

7. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Ferring B.V.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Bayer AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Braintree
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Bausch Health Companies Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Norgine B.V.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
• Analyst Views

8. Section

• References
• Research Methodology
• About Us and Sales Contact